146 related articles for article (PubMed ID: 26542336)
21. Cardiotoxicity and cardioprotection in breast cancer chemotherapy. The role of dexrazoxane.
Venturini M
Clin Ter; 1998; 149(921):5-6. PubMed ID: 9621480
[No Abstract] [Full Text] [Related]
22. Trastuzumab cardio-oncology: lessons learned.
Frankel C
Clin J Oncol Nurs; 2010 Oct; 14(5):630-40. PubMed ID: 20880820
[TBL] [Abstract][Full Text] [Related]
23. Benefits of trastuzumab outweigh its harms, says Cochrane review.
Wise J
BMJ; 2014 Jun; 348():g3835. PubMed ID: 24923809
[No Abstract] [Full Text] [Related]
24. Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?
Morris PG; Hudis CA
J Clin Oncol; 2010 Jul; 28(21):3407-10. PubMed ID: 20530269
[No Abstract] [Full Text] [Related]
25. Cardio-Oncology Programs Strive to Balance Cancer Care With Heart Health.
Hampton T
Circulation; 2016 Jul; 134(4):353-4. PubMed ID: 27462055
[No Abstract] [Full Text] [Related]
26. Trastuzumab-related cardiac events in the treatment of early breast cancer.
Fried G; Regev T; Moskovitz M
Breast Cancer Res Treat; 2013 Nov; 142(1):1-7. PubMed ID: 24154507
[TBL] [Abstract][Full Text] [Related]
27. [Promote multidisciplinary study on anthracycline-induced cardiotoxicity in children].
Chen SB; Huang MR; Tang JY
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):565-8. PubMed ID: 24225284
[No Abstract] [Full Text] [Related]
28. Controversies in the use of adjuvant trastuzumab (Herceptin).
Chowdhury S; Pickering L; Ellis P
J Br Menopause Soc; 2006 Dec; 12(4):172-4. PubMed ID: 17178019
[TBL] [Abstract][Full Text] [Related]
29. [Cardiac adverse events from non-cardiac drugs].
Monsuez JJ; Charniot JC
Ann Cardiol Angeiol (Paris); 1999 Jun; 48(6):447-53. PubMed ID: 12555343
[TBL] [Abstract][Full Text] [Related]
30. Current trials of cytotoxic and targeted agents in breast cancer: the caveat of radiotherapy.
Chargari C; Levy A; Védrine L; Magné N
Ann Oncol; 2011 May; 22(5):1243-1244. PubMed ID: 21292646
[No Abstract] [Full Text] [Related]
31. [Management of adverse effects by cancer chemotherapy for treatment of advanced breast cancers].
Kobayashi T; Fujii T; Yamazaki H; Ohkawa Y; Kuraishi Y; Inagaki J
Nihon Rinsho; 2000 Apr; 58 Suppl():298-310. PubMed ID: 11026010
[No Abstract] [Full Text] [Related]
32. [Chemotherapy and the heart].
Plana JC
Rev Esp Cardiol; 2011 May; 64(5):409-15. PubMed ID: 21492985
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant trastuzumab in breast cancer: experience from the University of Florence.
Livi L; Borghesi S; Meattini I; Saieva C; De Luca Cardillo C; Scotti V; Mangoni M; Galardi A; Cataliotti L; Paiar F; Bianchi S; Biti G
J Chemother; 2010 Apr; 22(2):115-8. PubMed ID: 20435571
[TBL] [Abstract][Full Text] [Related]
34. [Nurse's role in chemotherapy care].
Rovelon P
Soins; 2003 Mar; (673):37-9. PubMed ID: 12677922
[No Abstract] [Full Text] [Related]
35. Adult multicenter trials using dexrazoxane to protect against cardiac toxicity.
Swain SM
Semin Oncol; 1998 Aug; 25(4 Suppl 10):43-7. PubMed ID: 9768823
[TBL] [Abstract][Full Text] [Related]
36. Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.
Wonders KY; Reigle BS
Integr Cancer Ther; 2009 Mar; 8(1):17-21. PubMed ID: 19174506
[TBL] [Abstract][Full Text] [Related]
37. Herceptin in early breast cancer: a call for judicious use.
Thorat MA
Natl Med J India; 2005; 18(6):315-7. PubMed ID: 16483033
[No Abstract] [Full Text] [Related]
38. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
Ky B; Carver JR
Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
[TBL] [Abstract][Full Text] [Related]
39. Preventing Today's Survivors of Breast Cancer From Becoming Tomorrow's Cardiac Patients.
Nowsheen S; Duma N; Ruddy KJ
J Oncol Pract; 2018 Apr; 14(4):213-214. PubMed ID: 29641946
[No Abstract] [Full Text] [Related]
40. Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
Perik PJ; de Korte MA; van Veldhuisen DJ; Gietema JA; Sleijfer DT; de Vries EG
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1763-71. PubMed ID: 18062750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
